A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking
Study Details
Study Description
Brief Summary
This clinical trial compares a new smoking cessation smartphone application (app) (iCanQuit) to an existing smarphone app (National Cancer Institute [NCI] QuitGuide) for helping American Indians and Alaska Natives (AIANs) quit smoking. Compared to other racial/ethnic groups, AIANs have 6 times higher rates of developing smoking-related cancers, including lung cancer. Commercial cigarette smoking accounts for half of all deaths among AIANs nationwide. AIANs' often lack of access to smoking cessation interventions, which may be due to inequities in the healthcare system, lack of health insurance, living in rural areas, systemic racism, and historical trauma. There is also a lack of effective smoking cessation interventions for AIANs. Smartphone apps have the potential to deliver a low-cost smoking cessation intervention with wide reach to AIANs. Apps require no in-person delivery and no provider training, do not require integration into complex hospital systems, can be freely accessed on an app store, and are available at any time and any place. iCanQuit is a behavioral intervention designed to help adults stop smoking by teaching skills for coping with smoking urges, staying motivated, and preventing relapse. The iCanQuit app intervention may be more effective than the currently available NCI QuitGuide app at helping AIANs quit smoking.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants use the iCanQuit app, which includes setting up a personalized quit plan, participating in eight levels of the content, receiving on-demand help in coping with smoking urges, and tracking their daily smoking behaviors on study.
ARM II: Participants use the NCI QuitGuide app on study.
After completion of study intervention, patients are followed up at 3, 6, and 12-months.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Arm I (iCanQuit app) Participants use the iCanQuit app, which includes setting up a personalized quit plan, participating in eight levels of the content, receiving on-demand help in coping with smoking urges, and tracking their daily smoking behaviors on study. |
Procedure: Biospecimen Collection
Ancillary studies
Other Names:
Behavioral: Smoking Cessation Intervention
Use iCanQuit smartphone app
Other Names:
Other: Survey Administration
Ancillary studies
|
| Active Comparator: Arm II (NCI QuitGuide app) Participants use the NCI QuitGuide app on study. |
Procedure: Biospecimen Collection
Ancillary studies
Other Names:
Behavioral: Smoking Cessation Intervention
Use NCI QuitGuide smartphone app
Other Names:
Other: Survey Administration
Ancillary studies
|
Outcome Measures
Primary Outcome Measures
- 30-day point prevalence abstinence (PPA) [At 12 months post randomization]
Will be assessed based on self-report with biochemical verification of salivary cotinine. For each comparison of treatment arms on cessation outcomes, will use a logistic regression model.
Secondary Outcome Measures
- 30-day PPA [At 3- and 6-months post randomization]
Will be assessed based on self-report with biochemical verification of salivary cotinine. For each comparison of treatment arms on cessation outcomes, will use a logistic regression model.
- Self-reported 24-hour PPA [At the 3, 6, and 12-month follow-ups]
A secondary definition of cessation will include self-reported abstinence from cigarettes and all other commercial nicotine-containing tobacco products (i.e., e-cigarettes or vaping, chewing tobacco, snus, hookahs, cigars, cigarillos, tobacco pipes, kreteks). Will be assessed based on self-report with biochemical verification of salivary cotinine. For each comparison of treatment arms on cessation outcomes, will use a logistic regression model.
- Self-reported 7-day PPA [At the 3, 6, and 12-month follow-ups]
A secondary definition of cessation will include self-reported abstinence from cigarettes and all other commercial nicotine-containing tobacco products (i.e., e-cigarettes or vaping, chewing tobacco, snus, hookahs, cigars, cigarillos, tobacco pipes, kreteks). Will be assessed based on self-report with biochemical verification of salivary cotinine. For each comparison of treatment arms on cessation outcomes, will use a logistic regression model.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Self-identify as American Indian or Alaska Native, either alone or in combination with other races
-
Age 18 and older
-
Has smoked daily for the past year
-
Interest in quitting smoking within the next 30 days
-
Willing to be randomly assigned to either app
-
Have daily access to their own Android or iPhone
-
Able to download a smartphone app
-
Be willing and able to read English
-
Not currently or within past 30 days using other smoking cessation behavioral interventions or smoking cessation pharmacotherapies
-
Have never participated in our prior research
-
Have no other household or family member participating
-
Being willing to complete the 3, 6, and 12-month follow-up assessments
-
Providing email, phone number(s), and mailing address
-
Living off United States (US) AIAN tribal reservations or living on five Northern Plains tribal reservations from whom we would obtain approvals to recruit
Exclusion Criteria:
-
Currently (i.e., within past 30 days) using other smoking cessation behavioral interventions or pharmacotherapy to aid cessation
-
Has participated in our prior research trials
-
Has used the National Cancer Institute's (NCI's) QuitGuide app
-
Not willing to complete a follow-up survey at 3, 6, and 12 months post-randomization
-
Not providing email, phone number(s), and mailing address
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | United States | 98109 |
Sponsors and Collaborators
- Fred Hutchinson Cancer Center
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Jonathan B. Bricker, Fred Hutch/University of Washington Cancer Consortium
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RG1123796
- NCI-2023-09049
- RG1123796
- R01CA284687